Cite
MLA Citation
Ravi Savarirayan et al.. “Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies.” Therapeutic advances in musculoskeletal disease, vol. 14, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100169881084.0x00004e